Trying to build a portfolio that can survive recessions, inflation, and market volatility is one of the biggest challenges ...

Pharmaceutical stocks are getting more attention these days as the global drug market is expected to reach $1.21 trillion in 2025, showing why the industry matters so much. The growth is driven by new ...

Earnings season creates short-term winners and losers, companies whose shares rise or fall after they announce their ...

We recently published a list of 10 Magnificent Dividend Growth Stocks to Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other magnificent ...

AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets like ...

AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Dividend Paying Stocks to Buy Now. AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company that was spun off from Abbott Laboratories in 2013 and is ...

We recently published a list of S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Sentiment. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other ...

NORTH CHICAGO, Ill., June 20, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share. The cash dividend is payable August ...

Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...